JENNIFER HOLLENBECK: Open Payments
NPI 1336510411 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 13 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $44 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Alkermes, Inc. | 3 | $58 |
| Indivior Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
Products named: ARISTADA, SUBLOCADE, AUSTEDO XR, CAPLYTA, INGREZZA, UZEDY.
Industry payments across NY — which companies pay providers there.
